The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mechanisms leading to degeneration of dopaminergic neurons (DNs) in the substantia nigra of patients with Parkinson's disease (PD) are not completely understood. Here, we show, in the postmortem human tissue, that these neurons aberrantly express mitosis-associated proteins, including the E2F-1 transcription factor, and appear to duplicate their nuclear DNA. We further demonstrate that the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injected into mice and application of its active metabolite 1-methyl-4-phenylpyridinium to mesencephalic cultures activate the retinoblastoma–E2F pathway in postmitotic DNs. We also find that cell death rather than mitotic division followed the toxin-induced replication of DNA, as determined by BrdU incorporation in DNs. In addition, blocking E2F-1 transcription protected cultured DNs against 1-methyl-4-phenylpyridinium toxicity. Finally, E2F-1-deficient mice were significantly more resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic cell death than their wild-type littermates. Altogether, BrdU incorporation in mature neurons and lack of evidence for newborn neurons argue against neuronal turnover in normal conditions or during pathological states in the substantia nigra. Instead, our results demonstrate that mitosis-like signals are activated in mature DNs in patients with PD and mediate neuronal death in experimental models of the disease. Inhibition of mitosis-like signals may therefore provide strategies for neuroprotection in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [251]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation
Field, S. J., Tsai, F.-Y., Kuo, F., Zubiaga, A. M., Kaelin, W. G., Livingston, D. M., Orkin, S. H., & Greenberg, M. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81255-6 · Cited by 754
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yang, Y., Geldmacher, D. S., & Herrup, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02661.2001 · Cited by 616
The harlequin mouse mutation downregulates apoptosis-inducing factor
Klein, J. A., Longo-Guess, C. M., Rossmann, M. P., Seburn, K. L., Hurd, R. E., Frankel, W. N., Bronson, R. T., & Ackerman, S. L. (2002) · Nature · doi:10.1038/nature01034 · Cited by 605
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590
Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483
The Adult Substantia Nigra Contains Progenitor Cells with Neurogenic Potential
Lie, D. C., Dziewczapolski, G., Willhoite, A. R., Kaspar, B. K., Shults, C. W., & Gage, F. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06639.2002 · Cited by 449
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Self-citationDivide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
Herrup, K., Neve, R., Ackerman, S. L., & Copani, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3347-04.2004 · Cited by 287
Kuan, C.-Y., Schloemer, A. J., Lu, A., Burns, K. A., Weng, W.-L., Williams, M. T., Strauss, K. I., Vorhees, C. V., Flavell, R. A., Davis, R. J., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3883-04.2004 · Cited by 280
Self-citationHöglinger, G. U., Carrard, G., Michel, P. P., Medja, F., Lombès, A., Ruberg, M., Friguet, B., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01952.x · Cited by 253
Self-citationNo evidence for new dopaminergic neurons in the adult mammalian substantia nigra
Frielingsdorf, H., Schwarz, K., Brundin, P., & Mohapel, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401229101 · Cited by 251
Dopamine and adult neurogenesis
Borta, A., & Höglinger, G. U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04241.x · Cited by 192
Self-citationAlterations in G1 to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis
Ranganathan, S., & Bowser, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63879-5 · Cited by 160
Cycling at the interface between neurodevelopment and neurodegeneration
Nguyen, M. D., Mushynski, W. E., & Julien, J. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401108 · Cited by 150
Regulation of Neuronal Survival and Death by E2F-Dependent Gene Repression and Derepression
Liu, D. X., & Greene, L. A. (2001) · Neuron · doi:10.1016/s0896-6273(01)00495-0 · Cited by 142
Expression Patterns of Retinoblastoma Protein in Parkinson Disease
Jordan-Sciutto, K. L., Dorsey, R., Chalovich, E. M., Hammond, R. R., & Achim, C. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.68 · Cited by 121
Cell cycle molecules and vertebrate neuron death: E2F at the hub
Greene, L. A., Biswas, S. C., & Liu, D. X. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401341 · Cited by 117
To die or grow: Parkinson's disease and cancer
WEST, A., DAWSON, V, & DAWSON, T. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.05.002 · Cited by 117
Rideout, H. J., Wang, Q., Park, D. S., & Stefanis, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01237.2003 · Cited by 101
Cell Cycle Proteins Exhibit Altered Expression Patterns in Lentiviral-Associated Encephalitis
Jordan-Sciutto, K. L., Wang, G., Murphey-Corb, M., & Wiley, C. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02185.2002 · Cited by 73
El‐Khodor, B. F., Oo, T. F., Kholodilov, N. G., & Burke, R. E. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8047 · Cited by 59
Trinh, E., Boutillier, A., & Loeffler, J. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0928 · Cited by 38
Self-citation
Cited by
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Another study reported increased levels of the E2F-1 transcription factor in dopaminergic neurons in the substantia nigra of PD patients and suggested that the pRb/E2F-1 pathway is activated in these neurons which can lead to apoptosis [251].”
BackgroundRecent Advances in the Genetics of Parkinson's Disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 437
“In light of the finding that E2F-1 is aberrantly expressed in the brains of PD patients and that inappropriate expression of cell-division proteins in postmitotic neurons may lead to cell death (54), dysregulated translation may represent an important pathogenic output of mutant LRRK2.”
Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Gehrke, S., Imai, Y., Sokol, N., & Lu, B. (2010) · Nature · doi:10.1038/nature09191 · Cited by 398
Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287
“Cultured midbrain neurons treated with MPP? show immunostaining for phospho-pRB and E2F-1 [210].”
Influential
Metadata
- Authors
- Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., Hirsch, E. C., & Hunot, S.
- Affiliations
- Inserm (FR)
- Yale University (US)
- Philipps University of Marburg (DE)
- *Department of Experimental Neurology, Philipps University, 35039 Marburg, Germany;
- University of Colorado Denver (US)
- Department of Experimental Neurology and Therapeutics, Unité Mixte de Recherche 679, Institut National de la Santé et de la Recherche Médicale, 75013 Paris, France;
- Corresponding author
- Rakic, Pasko
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-02-27
- Volume
- 104
- Issue
- 9
- Pages
- 3585-3590
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1805567
- OpenAlex
- W2092598865
- Cited by
- 276
- References
- 25
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 8 · 2023: 7 · 2022: 6 · 2021: 14 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 22 · 2014: 17 · 2013: 19 · 2012: 16
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (LSHM-CT-2003-503330)
- Bundesministerium für Bildung und Forschung (01GO0201, BMBF-01GN0513, 01GN0513)
- National Institute of Mental Health (R24MH068855, R24MH68855)
- National Cancer Institute (R01CA077314)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, dopaminergic neurons, substantia nigra, retinoblastoma protein, E2F1, cell cycle, neuronal cell death, MPTP, MPP+, DNA replication, neuroprotection, postmitotic neurons
- MeSH terms
- Analysis of Variance, Animals, Chromatography, High Pressure Liquid, Gene Expression Regulation, Humans, Immunohistochemistry, Interneurons, Male, Mice, Inbred C57BL, Parkinson Disease, Substantia Nigra, Signal Transduction, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-Methyl-4-phenylpyridinium, Oligonucleotides, Antisense, Apoptosis, In Situ Hybridization, Mice, Knockout, E2F1 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.